Cannara Biotech Inc. (TSXV:LOVE)
1.780
-0.020 (-1.11%)
At close: Feb 25, 2026
Cannara Biotech Market Cap
Cannara Biotech has a market cap or net worth of CAD 175.83 million as of February 26, 2026. Its market cap has increased by 61.65% in one year.
Market Cap
175.83M
Enterprise Value
194.12M
Revenue
112.25M
Ranking
n/a
PE Ratio
14.93
Stock Price
1.78
Market Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 211.62M to 175.83M, a decrease of -16.91%. That is a compound annual growth rate of -2.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 175.83M | 6.39% |
| Dec 31, 2025 | 165.28M | 148.11% |
| Dec 31, 2024 | 66.61M | -10.84% |
| Dec 29, 2023 | 74.72M | -10.37% |
| Dec 30, 2022 | 83.36M | -29.55% |
| Dec 31, 2021 | 118.32M | 100.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurora Cannabis | 297.72M |
| TerrAscend | 294.99M |
| Organigram Global | 264.88M |
| BioSyent | 177.96M |
| Auxly Cannabis Group | 164.04M |
| Charlotte's Web Holdings | 158.09M |
| Ascend Wellness Holdings | 154.93M |
| Cardiol Therapeutics | 154.20M |